P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin Lin, Kris C. Wood, Justine C. Rutter et al.|Nature Cancer|2022Cited by 42
Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosisShane T. Killarney, Kris C. Wood, Rachel Washart et al.|Nature Communications|2023Cited by 37
ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cellsJillian Hattaway Luttman, Ann Marie Pendergast, Jacob P. Hoj et al.|Cell Reports|2021Cited by 18
CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in <i>PIK3CA</i> -Mutant Gastric CancerLyla J. Stanland, Micah A. Luftig, Hazel X. Ang et al.|Molecular Cancer Research|2023Cited by 13
ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1Benjamin Mayro, Ann Marie Pendergast, Jacob P. Hoj et al.|Proceedings of the National Academy of Sciences|2023Cited by 10